{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:08:10Z","timestamp":1785161290435,"version":"3.55.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,30]]},"DOI":"10.7759\/cureus.89064","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:01:21Z","timestamp":1753891281000},"source":"Crossref","is-referenced-by-count":2,"title":["Dupilumab-Induced Graves\u2019 Disease in an Adult With Chronic Rhinosinusitis and Nasal Polyposis"],"prefix":"10.7759","author":[{"given":"Catarina","family":"Gama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida A","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sequeira","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association guideline for the management of Graves\u2019 hyperthyroidism","volume":"7","author":"Kahaly GJ","year":"2018","unstructured":"Kahaly GJ, Bartalena L, Heged\u00fcs L, Leenhardt L, Poppe K, Pearce SH. 2018 European Thyroid Association guideline for the management of Graves\u2019 hyperthyroidism. Eur Thyroid J. 2018, 7:167-86. 10.1159\/000490384","journal-title":"Eur Thyroid J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13044-018-0046-9","article-title":"Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases","volume":"11","author":"Rydzewska M","year":"2018","unstructured":"Rydzewska M, Jaromin M, Pasierowska IE, Sto\u017cek K, Bossowski A. Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases. Thyroid Res. 2018, 11:2. 10.1186\/s13044-018-0046-9","journal-title":"Thyroid Res"},{"key":"ref3","unstructured":"Dupixent. (2024). Accessed. October 23, 2024: https:\/\/www.dupixenthcp.com\/crswnp\/dosage-and-admin."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-20-0030","article-title":"Painless thyroiditis in a dupilumab-treated patient","volume":"2020","author":"Narantsatsral D","year":"2020","unstructured":"Narantsatsral D, Junko T, Hideyuki I, et al.. Painless thyroiditis in a dupilumab-treated patient. Endocrinol Diabetes Metab Case Rep. 2020, 2020:10.1530\/EDM-20-0030","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-021-00526-1","article-title":"Dupilumab-related type 1 diabetes in a patient with atopic dermatitis: a case report","volume":"13","author":"Kurokawa Y","year":"2022","unstructured":"Kurokawa Y, Oikawa Y, Shimada A, Yajima K. Dupilumab-related type 1 diabetes in a patient with atopic dermatitis: a case report. Diabetol Int. 2022, 13:300-3. 10.1007\/s13340-021-00526-1","journal-title":"Diabetol Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.15586\/aei.v51i3.786","article-title":"Hyperthyroidism in a 15-year-old adolescent treated with dupilumab for severe allergic asthma and atopic dermatitis","volume":"51","author":"Tosca MA","year":"2023","unstructured":"Tosca MA, Olcese R, Girosi D, Casalini E, Scaglione M, Ciprandi G. Hyperthyroidism in a 15-year-old adolescent treated with dupilumab for severe allergic asthma and atopic dermatitis. Allergol Immunopathol (Madr). 2023, 51:181-5. 10.15586\/aei.v51i3.786","journal-title":"Allergol Immunopathol (Madr)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000501824","article-title":"Graves\u2019 disease induced by immune checkpoint inhibitors: a case report and review of the literature","volume":"8","author":"Brancatella A","year":"2019","unstructured":"Brancatella A, Viola N, Brogioni S, et al.. Graves\u2019 disease induced by immune checkpoint inhibitors: a case report and review of the literature. Eur Thyroid J. 2019, 8:192-5. 10.1159\/000501824","journal-title":"Eur Thyroid J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03718-2","article-title":"Thyroid disorders induced by immune checkpoint inhibitors","volume":"85","author":"Karaviti D","year":"2024","unstructured":"Karaviti D, Kani ER, Karaviti E, et al.. Thyroid disorders induced by immune checkpoint inhibitors. Endocrine. 2024, 85:67-79. 10.1007\/s12020-024-03718-2","journal-title":"Endocrine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3011","article-title":"Graves' hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease","volume":"99","author":"Rapoport B","year":"2014","unstructured":"Rapoport B, McLachlan SM. Graves' hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease. J Clin Endocrinol Metab. 2014, 99:4060-1. 10.1210\/jc.2014-3011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101388","article-title":"Graves' disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy","volume":"34","author":"Antonelli A","year":"2020","unstructured":"Antonelli A, Fallahi P, Elia G, et al.. Graves' disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab. 2020, 34:101388. 10.1016\/j.beem.2020.101388","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/344374-dupilumab-induced-graves-disease-in-an-adult-with-chronic-rhinosinusitis-and-nasal-polyposis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:01:22Z","timestamp":1753891282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/344374-dupilumab-induced-graves-disease-in-an-adult-with-chronic-rhinosinusitis-and-nasal-polyposis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.89064","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,30]]}}}